A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment

BACKGROUND: Brain metastasis (BM) comprises the most common reason for crizotinib failure in patients with anaplastic lymphoma kinase (ALK)‐rearranged non–small cell lung cancer (NSCLC). We hypothesize that its occurrence could be predicted by a computed tomography (CT)‐based radiomics model, theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yongluo, Wang, Yixing, Fu, Sha, Chen, Tao, Zhou, Yixin, Zhang, Xuanye, Chen, Chen, He, Li‐na, Du, Wei, Li, Haifeng, Lin, Zuan, Zhao, Yuanyuan, Yang, Yunpeng, Zhao, Hongyun, Fang, Wenfeng, Huang, Yan, Hong, Shaodong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161316/
https://www.ncbi.nlm.nih.gov/pubmed/35437945
http://dx.doi.org/10.1111/1759-7714.14386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161316/
https://www.ncbi.nlm.nih.gov/pubmed/35437945
http://dx.doi.org/10.1111/1759-7714.14386

Ejemplares similares